• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清肌酐水平升高与抗 NMDAR 脑炎女性患者精神症状的改善有关。

High serum creatinine is associated with reduction of psychiatric symptoms in female patients with anti-NMDAR encephalitis.

机构信息

Department of Neurology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jing Wu Road, Huaiyin District, Jinan, 250021, Shandong, China.

Department of Neurology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jing Wu Road, Huaiyin District, Jinan, 250021, Shandong, China.

出版信息

Neurosci Lett. 2021 Feb 16;746:135650. doi: 10.1016/j.neulet.2021.135650. Epub 2021 Jan 21.

DOI:10.1016/j.neulet.2021.135650
PMID:33485991
Abstract

OBJECTIVE

Serum creatinine (SCR) has been shown to be associated with many neurodegenerative diseases. In this study, we investigated the relationship between SCR levels and the incidence of psychiatric symptoms in patients with anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis.

METHODS

The SCR levels were tested in 69 patients with anti-NMDAR encephalitis at admission. Clinical characteristics and blood and CSF parameters were compared between the group of patients with psychiatric symptoms (P + group) and the group of those without psychiatric symptoms (P- group). The association between SCR and the incidence of psychiatric symptoms was determined by multivariate-adjusted linear regression analyses.

RESULTS

The SCR levels in the P + group were significantly lower than those in the P- group (P < 0.001). In the female subgroup, the SCR levels in the P + group were significantly lower compared to the P- group (P < 0.001), whereas in the male subgroup, the SCR levels did not differ between the two groups (P = 0.084). Furthermore, the highest SCR tercile overall had a significantly lower incidence of psychiatric symptoms than the lowest tercile (P < 0.001), and a significant negative correlation between the SCR levels and the occurrence of psychiatric symptoms was observed (r = -0.392, P < 0.001). Multivariate logistic regression analysis showed that the association was independent after adjusting for age, cystatin C and the modified Rankin Scale (mRS) score (P = 0.001). A similar result was found in the female subgroup (P = 0.010), but not in the male subgroup (P = 0.225).

CONCLUSION

Our study indicated that the SCR level was negatively correlated with incidence of psychiatric symptoms in female patients, and higher SCR level could be a protective factor for psychiatric symptoms in female patients with anti-NMDAR encephalitis.

摘要

目的

血清肌酐(SCR)已被证明与许多神经退行性疾病有关。在这项研究中,我们调查了血清肌酐水平与抗 N-甲基-D-天冬氨酸受体(抗 NMDAR)脑炎患者精神症状发生率之间的关系。

方法

在入院时,对 69 例抗 NMDAR 脑炎患者进行了 SCR 水平检测。比较有精神症状组(P+组)和无精神症状组(P-组)之间的临床特征和血液及脑脊液参数。通过多元调整线性回归分析确定 SCR 与精神症状发生率之间的关联。

结果

P+组的 SCR 水平明显低于 P-组(P < 0.001)。在女性亚组中,P+组的 SCR 水平明显低于 P-组(P < 0.001),而在男性亚组中,两组间 SCR 水平无差异(P = 0.084)。此外,总体上 SCR 三分位最高组的精神症状发生率明显低于三分位最低组(P < 0.001),且 SCR 水平与精神症状发生呈显著负相关(r = -0.392,P < 0.001)。多元逻辑回归分析显示,在校正年龄、胱抑素 C 和改良 Rankin 量表(mRS)评分后,这种关联仍然存在(P = 0.001)。在女性亚组中也得到了类似的结果(P = 0.010),但在男性亚组中则没有(P = 0.225)。

结论

我们的研究表明,SCR 水平与女性患者精神症状发生率呈负相关,较高的 SCR 水平可能是女性抗 NMDAR 脑炎患者精神症状的保护因素。

相似文献

1
High serum creatinine is associated with reduction of psychiatric symptoms in female patients with anti-NMDAR encephalitis.血清肌酐水平升高与抗 NMDAR 脑炎女性患者精神症状的改善有关。
Neurosci Lett. 2021 Feb 16;746:135650. doi: 10.1016/j.neulet.2021.135650. Epub 2021 Jan 21.
2
Serum cystatin C and anti-N-methyl-D-aspartate receptor encephalitis.血清胱抑素 C 与抗 N-甲基-D-天冬氨酸受体脑炎。
Acta Neurol Scand. 2018 May;137(5):515-522. doi: 10.1111/ane.12894. Epub 2018 Jan 7.
3
Serum uric acid and anti-N-methyl-d-aspartate receptor encephalitis.血清尿酸与抗N-甲基-D-天冬氨酸受体脑炎
Neurochem Int. 2017 Sep;108:34-39. doi: 10.1016/j.neuint.2017.02.005. Epub 2017 Feb 10.
4
Lipid Metabolism in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.抗N-甲基-D-天冬氨酸受体脑炎患者的脂质代谢
Neuroimmunomodulation. 2017;24(4-5):256-263. doi: 10.1159/000485623. Epub 2018 Feb 1.
5
Serum complement levels in anti-N-methyl-d-aspartate receptor encephalitis.抗 N-甲基-D-天冬氨酸受体脑炎患者的血清补体水平。
Eur J Neurol. 2018 Jan;25(1):178-184. doi: 10.1111/ene.13495. Epub 2017 Nov 17.
6
Serum Bilirubin and Albumin in Anti-N-Methyl-D-Aspartate Receptor Encephalitis.抗 N-甲基-D-天冬氨酸受体脑炎患者的血清胆红素和白蛋白。
Neuroimmunomodulation. 2018;25(4):206-214. doi: 10.1159/000494801. Epub 2018 Nov 29.
7
Comparisons between Psychiatric Symptoms of Patients with Anti-NMDAR Encephalitis and New-Onset Psychiatric Patients.抗 NMDAR 脑炎患者与新发精神病患者的精神症状比较。
Neuropsychobiology. 2017;75(2):72-80. doi: 10.1159/000480514. Epub 2017 Oct 24.
8
Association of serum Gasdermin D with anti-N-methyl-D-aspartate receptor encephalitis.血清 GSDMD 与抗 N-甲基-D-天冬氨酸受体脑炎的相关性。
J Neurochem. 2021 Dec;159(5):923-930. doi: 10.1111/jnc.15497. Epub 2021 Sep 1.
9
Thyroid Function and Autoimmune Indications in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.抗N-甲基-D-天冬氨酸受体脑炎患者的甲状腺功能及自身免疫指标
Neuroimmunomodulation. 2018;25(2):110-117. doi: 10.1159/000492179. Epub 2018 Aug 29.
10
Elevated CHI3L1 and OPN levels in patients with anti-N-methyl-d-aspartate receptor encephalitis.抗 N-甲基-D-天冬氨酸受体脑炎患者 CHI3L1 和 OPN 水平升高。
J Neuroimmunol. 2019 Sep 15;334:577005. doi: 10.1016/j.jneuroim.2019.577005. Epub 2019 Jul 9.

引用本文的文献

1
Development of a prediction model integrating PD-1 and ICOS for early differential diagnosis between autoimmune and viral encephalitis.整合PD-1和ICOS的预测模型用于自身免疫性脑炎与病毒性脑炎早期鉴别诊断的研究
Front Immunol. 2025 Apr 25;16:1550963. doi: 10.3389/fimmu.2025.1550963. eCollection 2025.
2
Mendelian randomization study of the relationship between blood and urine biomarkers and schizophrenia in the UK Biobank cohort.英国生物银行队列中血液和尿液生物标志物与精神分裂症关系的孟德尔随机化研究。
Commun Med (Lond). 2024 Mar 7;4(1):40. doi: 10.1038/s43856-024-00467-1.